HIV Protease Inhibitors in Pregnancy: Pharmacology and Clinical UseANDANY, Nisha; LOUTFY, Mona R.Drugs (Basel). 2013, Vol 73, Num 3, pp 229-247, issn 0012-6667, 19 p.Article

Treatment of HIV infection in pregnant women: Antiretroviral management optionsLOUTFY, Mona R; WALMSLEY, Sharon L.Drugs (Basel). 2004, Vol 64, Num 5, pp 471-488, issn 0012-6667, 18 p.Article

Factors affecting banking quality of umbilical cord blood for transplantationHONGYOU YANG; LOUTFY, Mona R; MAYERHOFER, Stephanie et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 2, pp 284-292, issn 0041-1132, 9 p.Article

A review of reproductive health research, guidelines and related gaps for women living with HIVLOUTFY, Mona R; SONNENBERG-SCHWAN, Ulrike; MARGOLESE, Shari et al.AIDS Care (Print). 2013, Vol 25, Num 5-6, pp 657-666, issn 0954-0121, 10 p.Article

Inclusion body myositis: another possible manifestation of antiretroviral-associated mitochondrial toxicityLOUTFY, Mona R; SHEEHAN, Nancy L; GOODHEW, John E et al.AIDS (London). 2003, Vol 17, Num 8, pp 1266-1267, issn 0269-9370, 2 p.Article

Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic areaLOUTFY, Mona R; WILSON, Marianna; KEYSTONE, Jay S et al.The American journal of tropical medicine and hygiene. 2002, Vol 66, Num 6, pp 749-752, issn 0002-9637Article

HIV Postexposure Prophylaxis Use Among Ontario Female Adolescent Sexual Assault Victims : A Prospective AnalysisDU MONT, Janice; MYHR, Terri L; HUSSON, Heather et al.Sexually transmitted diseases. 2008, Vol 35, Num 12, pp 973-978, issn 0148-5717, 6 p.Article

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment- Experienced Patients with Drug- Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III TrialsSTEIGBIGEL, Roy T; COOPER, David A; YENI, Patrick et al.Clinical infectious diseases. 2010, Vol 50, Num 4, pp 605-612, issn 1058-4838, 8 p.Article

Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophyANTONIOU, Tony; RABOUD, Janet M; KOVACS, Colin et al.AIDS Care (Print). 2009, Vol 21, Num 10, pp 1247-1252, issn 0954-0121, 6 p.Article

Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivoZILIN NIE; BREN, Gary D; DOUEK, Daniel C et al.Journal of virology. 2007, Vol 81, Num 13, pp 6947-6956, issn 0022-538X, 10 p.Article

CD4⁺ cell count increase predicts clinical benefits in patients with advanced hiv disease and persistent viremia after 1 year of combination antiretroviral therapyLOUTFY, Mona R; WALMSLEY, Sharon L; MULLIN, Christopher M et al.The Journal of infectious diseases. 2005, Vol 192, Num 8, pp 1407-1411, issn 0022-1899, 5 p.Article

Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, CanadaBENOIT, Anita C; LIGHT, Lucia; BURCHELL, Ann N et al.AIDS Care (Print). 2014, Vol 26, Num 5-6, pp 694-701, issn 0954-0121, 8 p.Article

Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohortNDUMBI, Patricia; GILLIS, Jennifer; TSOUKAS, Chris M et al.AIDS (London). 2013, Vol 27, Num 18, pp 2863-2872, issn 0269-9370, 10 p.Article

A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 WeeksGATHE, Joseph; DA SILVA, Barbara A; BERNSTEIN, Barry et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 5, pp 474-481, issn 1525-4135, 8 p.Conference Paper

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 InfectionCOOPER, David A; STEIGBIGEL, Roy T; SCHECHTER, Mauro et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 355-365, issn 0028-4793, 11 p.Article

Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two casesJAWORSKY, Denise; THOMPSON, Courtney; YUDIN, Mark H et al.Antiviral therapy (London). 2010, Vol 15, Num 4, pp 585-588, issn 1359-6535, 4 p.Article

The Recombinant Hepatitis B Surface Antigen Vaccine in Persons With HIV: Is Seroconversion Sufficient for Long-term Protection?POWIS, Jeff E; RABOUD, Janet; OSTROWSKI, Mario et al.The Journal of infectious diseases. 2012, Vol 205, Num 10, pp 1534-1538, issn 0022-1899, 5 p.Article

Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionSTEIGBIGEL, Roy T; COOPER, David A; KATLAMA, Christine et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 339-354, issn 0028-4793, 16 p.Article

Canadian HIV Pregnancy Planning GuidelinesLOUTFY, Mona R; MARGOLESE, Shari; MONEY, Deborah M et al.International journal of gynaecology and obstetrics. 2012, Vol 119, Num 1, pp 89-99, issn 0020-7292, 11 p.Article

Infectious Complications of Bio-Alcamid Filler Used for HIV-Related Facial LipoatrophyNADARAJAH, Jeya T; COLLINS, Micaela; RABOUD, Janet et al.Clinical infectious diseases. 2012, Vol 55, Num 11, pp 1568-1574, issn 1058-4838, 7 p.Article

Trimethoprim-Sulfamethoxazole-Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System: A Population-Based StudyANTONIOU, Tony; GOMES, Tara; JUURLINK, David N et al.Archives of internal medicine (1960). 2010, Vol 170, Num 12, pp 1045-1049, issn 0003-9926, 5 p.Article

Predictive value of immune parameters before treatment interruption (TI) for CD4⁺ T―cell count change during TI in HIV infectionHUANG, Kenneth H; LOUTFY, Mona R; BOULET, Salix et al.Antiviral therapy (London). 2009, Vol 14, Num 3, pp 381-392, issn 1359-6535, 12 p.Article

Severe acute respiratory syndromeCHRISTIAN, Michael D; POUTANEN, Susan M; LOUTFY, Mona R et al.Clinical infectious diseases. 2004, Vol 38, Num 10, pp 1420-1427, issn 1058-4838, 8 p.Article

Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use historyCESCON, Angela; CHAN, Keith; HOGG, Robert S et al.AIDS (London). 2014, Vol 28, Num 1, pp 121-127, issn 0269-9370, 7 p.Article

Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trialCHEGE, Duncan; KOVACS, Colin; KAUL, Rupert et al.AIDS (London). 2012, Vol 26, Num 2, pp 167-174, issn 0269-9370, 8 p.Article